what company makes tirzepatide Microdosing Tirzepatide - Wikipedia

Compounding pharmacies selling GLP-1 copycats are at higher risk of enforcement actions or cease-and-desist orders

Gard, D

older, non-selective agents are available for different routes of administration [i.e., oral (PO), intramuscular (IM), and intravenous (IV)] and continue to be investigated actively (Henter et al., 2017

We found that ~50% of the GLP-1 dependent LAG-1 accumulation required lst-1 and sygl-1 activity

So I like to share with people these are signals, not that we need to, you know, try to, as they say now, look smacks or anything like that, but do things that are beneficial more for the inside than the outside